Zscaler, Inc.

**Signal Note: Eventide Adds Cybersecurity Position** Eventide's new $603K position in Zscaler represents a notable departure from core biotech holdings, suggesting conviction in cloud security infrastructure as a secular growth theme. While outside traditional pharma, the move may reflect portfolio diversification or positioning ahead of enterprise IT spending cycles, though the catalyst timing remains unclear.